{"id":16285,"date":"2017-12-13T19:20:23","date_gmt":"2017-12-13T19:20:23","guid":{"rendered":"https:\/\/sffd.ch\/suisse-du-nord\/"},"modified":"2019-11-18T21:30:35","modified_gmt":"2019-11-18T21:30:35","slug":"expert-fabry-suisse-du-nord","status":"publish","type":"page","link":"https:\/\/sffd.ch\/fr\/expert-fabry-suisse-du-nord\/","title":{"rendered":"Suisse du Nord"},"content":{"rendered":"

[vc_row css_animation=\u00a0\u00bb\u00a0\u00bb row_type=\u00a0\u00bbrow\u00a0\u00bb use_row_as_full_screen_section=\u00a0\u00bbno\u00a0\u00bb type=\u00a0\u00bbfull_width\u00a0\u00bb angled_section=\u00a0\u00bbno\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb background_image_as_pattern=\u00a0\u00bbwithout_pattern\u00a0\u00bb][vc_column][vc_column_text]<\/p>\n

Expert Fabry en Suisse du Nord<\/h1>\n
\n
<\/div>\n
<\/div>\n
<\/div>\n<\/div>\n

[\/vc_column_text][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb][\/vc_column][\/vc_row][vc_row css_animation=\u00a0\u00bb\u00a0\u00bb row_type=\u00a0\u00bbrow\u00a0\u00bb use_row_as_full_screen_section=\u00a0\u00bbno\u00a0\u00bb type=\u00a0\u00bbfull_width\u00a0\u00bb angled_section=\u00a0\u00bbno\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb background_image_as_pattern=\u00a0\u00bbwithout_pattern\u00a0\u00bb][vc_column width=\u00a0\u00bb1\/6″][vc_column_text]\"\"[\/vc_column_text][\/vc_column][vc_column width=\u00a0\u00bb5\/6″][vc_column_text]<\/p>\n

PD Dr. med. Albina Nowak-Wilhelm<\/h4>\n

Ober\u00e4rztin
\nKlinik f\u00fcr Endokrinologie, Diabetologie und Klinische Ern\u00e4hrung
\nUniversit\u00e4tsspital Z\u00fcrich
\nR\u00e4mistrasse 100
\n8091 Z\u00fcrich
\nTel.: +41 (0)44 255 36 20
\nChef\u00e4rztin
\nInternistischer Dienst
\nPsychiatrische Universit\u00e4tsklinik Z\u00fcrich
\nLenggstrasse 31, Postfach
\n8032 Z\u00fcrich
\nTel.: +41 (0)44 384 23 21
\nEmail: albina.nowak@usz.ch<\/a><\/p>\n

\n
<\/div>\n
<\/div>\n
<\/div>\n<\/div>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row css_animation=\u00a0\u00bb\u00a0\u00bb row_type=\u00a0\u00bbrow\u00a0\u00bb use_row_as_full_screen_section=\u00a0\u00bbno\u00a0\u00bb type=\u00a0\u00bbfull_width\u00a0\u00bb angled_section=\u00a0\u00bbno\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb background_image_as_pattern=\u00a0\u00bbwithout_pattern\u00a0\u00bb][vc_column][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb][\/vc_column][\/vc_row][vc_row css_animation=\u00a0\u00bb\u00a0\u00bb row_type=\u00a0\u00bbrow\u00a0\u00bb use_row_as_full_screen_section=\u00a0\u00bbno\u00a0\u00bb type=\u00a0\u00bbfull_width\u00a0\u00bb angled_section=\u00a0\u00bbno\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb background_image_as_pattern=\u00a0\u00bbwithout_pattern\u00a0\u00bb][vc_column]

\n\t

\n\n\t \n Formation <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
\n
\n [vc_column_text]<\/p>\n\n\n\n\n\n\n\n\n\n\n\n
12\/2017<\/td>\nHabilitation \u201cRare inherited diseases with multiorgan involvement in adults. Fabry Disease as an example\u00bb.<\/td>\n<\/tr>\n
Since 02\/2017<\/td>\nAdvanced Studies for Master Degree in Pharmaceutical Medicine Clinical Trials Center USZ and University Basel<\/td>\n<\/tr>\n
2015<\/td>\nCourse of Descriptive Biostatistics and Regression Analysis with exercises, passed exam and achievement of European Credit Transfer and Accumulation System (ECTS) point; University of Zurich, Institute for Epidemiology, Biostatistics and Prevention<\/td>\n<\/tr>\n
2014<\/td>\nAttendant Elective \u201eScientific writing\u201c at the University of Zurich<\/td>\n<\/tr>\n
1999-2003<\/td>\nScientific research fellow, establishing and leading the Living Organ Donors Registry; Doctoral Thesis \u201cLong-term consequences of living kidney donation with distinction \u201cmagna cum laude\u201d, Department of Nephrology, University Hospital Frankfurt, Germany<\/td>\n<\/tr>\n
1997-2003<\/td>\nMedical School Universities of Frankfurt am Main and Rostock, Germany, King`s College London; degree \u2013 outstanding; final written exam with ranking among the best 0.3% in Germany<\/td>\n<\/tr>\n
1993-1997<\/td>\nAttending Night High School Diploma (Abendmatura), Villingen-Schwenningen, Germany. Price for outstanding achievements in Natural Sciences. On parallel, full-time occupation as nephrology nurse<\/td>\n<\/tr>\n
1995<\/td>\nEduction as Speciality Nurse for Nephrology and Dialysis, Price for the best passed exams, University Hospital Ulm, Germany<\/td>\n<\/tr>\n
1990-1993<\/td>\nGeneral Nurse School Oberndorf a. N., Germany<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

[\/vc_column_text] <\/div>\n<\/div>

\n\n\t \n Carri\u00e8re <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
\n
\n [vc_column_text]<\/p>\n\n\n\n\n\n\n\n\n\n\n\n
Since 07\/2018<\/td>\nSenior Consultant (Ober\u00e4rztin), Department of Endocrinology and Clinical Nutrition, UHZ: 50%<\/td>\n<\/tr>\n
Since 01\/2018<\/td>\nHead Physician (Chef\u00e4rztin), Internal Medicine, University Hospital of Psychiatry Zurich: 50%<\/td>\n<\/tr>\n
01\/2018-07\/2018<\/td>\nSenior Researcher and Lecturer Cardiology Department UHZ<\/td>\n<\/tr>\n
10\/2010-01\/2018<\/td>\nSenior Consultant (Ober\u00e4rztin), Department of Internal Medicine, UHZ<\/td>\n<\/tr>\n
07\/2008-11\/2010<\/td>\nSenior House Officer, Department of Internal Medicine; Speciality Registrar, Division of Nephrology University Hospital Basel<\/td>\n<\/tr>\n
04\/2009-10\/2009<\/td>\nRegistrar Intensive Care Unit, Royal Sussex County Hospital Brighton, UK: Exchange program via Basel University<\/td>\n<\/tr>\n
07\/2007-06\/2008<\/td>\nSenior House Officer, Department of Internal Medicine Spitalzentrum Biel<\/td>\n<\/tr>\n
04\/2004-04\/2007<\/td>\nSenior House Officer, Department of Internal Medicine Speciality; Registrar Department of Nephrology University Hospital Bern<\/td>\n<\/tr>\n
1993-1997<\/td>\nNurse as a full time job, Department of Nephrology and Hemodialysis Villingen-Schwenningen, Germany.
\nOn parallel, High School Diploma (matura), after 6pm.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

[\/vc_column_text] <\/div>\n<\/div>

\n\n\t \n Responsabilit\u00e9s <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
\n
\n [vc_column_text]<\/p>\n
    \n
  • Leading specialized consultation in storage disorders. Focus on Fabry Disease and other rare inborn Disorders. Clinical and research work, supervision of young doctors, teaching of medical students, treatment of out- und inpatients.<\/li>\n<\/ul>\n

    [\/vc_column_text] <\/div>\n<\/div>

    \n\n\t \n Enseignement <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
    \n
    \n [vc_column_text]<\/p>\n
      \n
    • \n
        Since November 2010, regular teaching of medical students University of Zurich in the 2nd and 3rd years Bachelor BMed as well as 1st and 3rd years MMed.<\/ul>\n<\/li>\n<\/ul>\n

        [\/vc_column_text] <\/div>\n<\/div>

        \n\n\t \n Adh\u00e9sions et participation aux conseils et aux panels <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
        \n
        \n [vc_column_text]<\/p>\n
          \n
        • \n
            \n
          • Swiss Society of General Internal Medicine<\/li>\n
          • Swiss Society of Nephrology<\/li>\n
          • Swiss Society of Hypertension<\/li>\n
          • Swiss Group for Inborn Errors of Metabolism<\/li>\n
          • Medical Board of Fabry Suisse and Lysosuisse (patients`organisation)<\/li>\n
          • Lead of multidisciplinary Fabry Boards, taking place at USZ three-monthly<\/li>\n
          • European Board of Fabry Registry<\/li>\n<\/ul>\n

            [\/vc_column_text] <\/div>\n<\/div>

            \n\n\t \n Honneurs, prix <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
            \n
            \n [vc_column_text]<\/p>\n\n\n\n\n\n\n
            23\/11\/2017<\/td>\nHemmi-Price for the Project Effect of intravenous iron versus placebo on cerebral dopamine receptor density in non-anemic premenopausal women with low ferritin levels and fatigue.<\/td>\n<\/tr>\n
            03\/2017<\/td>\nFirst best poster at the International Fabry Experts Meeting Berlin \u201cLong-term outcome of kidney transplantation in Fabry disease\u201d<\/td>\n<\/tr>\n
            03\/2017<\/td>\nSecond best poster at the International Fabry Experts Meeting Berlin \u201cPhenotype, Disease Severity and Genotype Reflected by Serum LysoGb3 Levels in Patients with Fabry Disease\u201d<\/td>\n<\/tr>\n
            2012<\/td>\nFirst Price of the Swiss Society of Internal Medicine for publication \u201cDirect comparison of three natriuretic peptides for prediction of short- and long-term mortality in patients with community-acquired pneumonia\u201d<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

            [\/vc_column_text] <\/div>\n<\/div>

            \n\n\t \n Langues <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
            \n
            \n [vc_column_text]<\/p>\n
              \n
            • German<\/li>\n
            • English<\/li>\n
            • Russisch<\/li>\n<\/ul>\n

              [\/vc_column_text] <\/div>\n<\/div>

              \n\n\t \n Publications <\/span>\n<\/span>\n\n \n <\/span>\n <\/span>\n <\/span>\n<\/span>\n<\/h4>\n
              \n
              \n [vc_column_text]<\/p>\n

              ORIGINAL ARTICLES<\/h4>\n
                \n
              1. Gossmann J, Wilhelm A, Kachel H. G., Jordan J, Sann U, Geiger H, Kramer W, Scheuermann EH
                \nLong-term consequences of live kidney donation follow-up in 93% of living kidney donors in a single transplant center
                \nAm J Transplant. 2005;5(10):2417-24<\/li>\n
              2. Hamscho N, Wilhelm A, D\u00f6bert N, Menzel C, Gossmann J, Berner U, Zaplatnikov K, Scheuermann EH, Gr\u00fcnwald F
                \nResidual kidney function after donor nephrectomy. Assessment by 99mTc-MAG3-clearance
                \nNuklearmedizin. 2005;44(5):200-4<\/li>\n
              3. Jordan J, Sann U, Janton A, Gossmann J, Kramer W, Kachel HG, Wilhelm A, Scheuermann EH
                \nLiving kidney donors’ long-term psychological status and health behavior after nephrectomy – a retrospective study
                \nJ Nephrol. 2004;17(5):728-35<\/li>\n
              4. Hofmann L, Simon-Zoula S, Nowak A, Giger A, Vock P, Boesch C, Frey F, Vogt B.
                \nBOLD-MRI for the assessment of renal oxygenation in humans: Acute effect of nephrotoxic xenobiotics
                \nKidney Int. 70(1):144-50<\/li>\n
              5. Sollinger D, Mohaupt MG, Wilhelm A, Uehlinger D, Frey FJ, Eisenberger U
                \nArterial stiffness assessed by digital volume pulse correlates with comorbidity in patients with ESRD
                \nAm J Kidney Dis. 2006;48(3):456-63<\/li>\n
              6. Breidthardt T, Socrates T, Noveanu M, Klima T, Heinisch C, Reichlin T, Potocki M, Nowak A, Tschung C, Arenja N, Bingisser R, Mueller C.
                \nImpact and Clinical Prediction of Worsening Renal Function in Acute Decompensated Heart Failure
                \nAm J Cardiol. 2011;107(5):730-5<\/li>\n
              7. Nowak A, Breidthardt T, Christ-Crain M, Bingisser R, Meune C, Tanglay Y, Heinisch C, Reiter M, Drexler B, Arenja N, Twerenbold R, Stolz D, Tamm M, M\u00fcller B, M\u00fcller C
                \nDirect Comparison of Three Natriuretic Peptides for Prediction of Short- and Long-term Mortality in Patients With Community-Acquired Pneumonia
                \nChest. 2012;141(4):974-82.<\/li>\n
              8. Nowak A, Breidthardt T, Dejung S, Christ-Crain M, Bingisser R, Drexler B, Meune C, Marono D, Mosimann T, M\u00fcller B, M\u00fcller C
                \nNatriuretic Peptides for early prediction of acute kidney injury in community acquired pneumonia
                \nClinica Chimica Acta, 2013 Apr 18;419:67-72<\/li>\n
              9. Artunc F, Nowak A, Mueller C, Breidthardt T, Twerenbold R, Wagner R, Friedrich B
                \nPlasma concentrations of the vasoactive peptides mid-regional pro-adrenomedullin, copeptin and c-terminal pro-endothelin 1 in hemodialysis patients: associated factors and prediction of mortality
                \nPLoS One. 2014 Jan 22;9(1):e86148<\/li>\n
              10. Fauch\u00e8re I, Moormann D, Maier W, Altweg L, L\u00fcscher T, Gr\u00fcnenfelder J, Nowak A, T\u00fcller D, Genoni M, Falk V, Hermann M
                \nRehabilitation After TAVI Compared To Surgical Aortic Valve Replacement
                \nInt J Cardiol. 2014 May 15;173(3):564-6<\/li>\n
              11. Nowak A, Friedrich B, Artunc F, Serra AL, Breidthardt T, Twerenbold R, Peter M, Potocki M, Mueller C
                \nPrognostic value and link to atrial fibrillation of soluble Klotho and FGF23 in hemodialysis patients
                \nPLoS One. 2014 Jul 3;9(7):e100688<\/li>\n
              12. Muskalla AM, Suter PM, Saur M, Nowak A, Hersberger M, Krayenbuehl PA
                \nG-Protein Receptor Kinase 4 Polymorphism and Response to Antihypertensive Therapy
                \nClin Chem. 2014 Dec;60(12):1543-8<\/li>\n
              13. Artunc F, Nowak A, M\u00fcller C, Peter A, Heyne N, H\u00e4ring H-U, Friedrich B
                \nMortality prediction using modern peptide biomarkers in hemodialysis patients \u2013 a comparative analysis
                \nKidney Blood Press Res. 2014 Dec 15;39(6):563-572<\/li>\n
              14. Nowak A, Artunc F, Serra A, M\u00fcller C, Pollock E, Krayenbuehl P-A, Friedrich B
                \nSclerostin and other circulating bone remodeling markers in hemodialysis patients
                \nKidney Blood Press Res. 2015;40(3):266-76<\/li>\n
              15. Weidmann ZM, Breidthardt T, Twerenbold R, Z\u00fcsli C, Nowak A, von Eckardstein A, Erne P, Rentsch K, de Oliveira MT Jr, Gualandro D, Maeder MT, Rubini Gimenez M, Pershyna K, Stallone F, Haas L, Jaeger C, Wildi K, Puelacher C, Honegger U, Wagener M, Wittmer S, Schumacher C, Krivoshei L, Hillinger P, Osswald S, Mueller C
                \nPrediction of mortality using quantification of renal function in acute heart failure
                \nInt J Cardiol.. 2015 Dec 15;201:650-7<\/li>\n
              16. Schmied C, Nowak A, Gruner C, Olinger E, Debaix H, Brauchlin A, Frank M, Reidt S, Monney P, Barbey F, Shah D, Namdar M
                \nThe value of ECG parameters as markers of treatment response in Fabry cardiomyopathy
                \nHeart. 2016 Aug 15;102(16):1309-14<\/li>\n
              17. Nowak A, Mechtler TP, Desnick RJ, Kasper DC
                \nPlasma LysoGb3: A useful biomarker for the diagnosis and treatment of Fabry disease heterozygotes
                \nMol Genet Metab. 2017 Jan – Feb;120(1-2):57-61<\/li>\n
              18. Nowak A, Boesch L, Andres E, Battegay E, Hornemann T, Schmid C, Bischoff-Ferrari H, Suter P, Krayenbuehl P-A
                \nEffect of vitamin D3 on self-perceived fatigue: a double-blind randomized placebo-controlled trial.
                \nMedicine, (Baltimore). 2016 Dec;95(52):e5353<\/li>\n
              19. Nowak A, Koch G, Huynh-Do U, Siegenthaler M, Marti H-P, Pfister M
                \nDisease progression modeling to evaluate the effects of enzyme replacement therapy on kidney function in adult patients with the Classic phenotype of Fabry disease.
                \nKidney Blood Press Res. 2017;42(1):1-15.<\/li>\n
              20. Menghini M, Pr\u00fcnte Ch, Krayenbuehl PA, Nowak A
                \nAssessment of drusen and other retinal degenerative changes in patients with hereditary hemochromatosis
                \nRetina. 0:1\u20136, 2017
                \n21. Saleh L, Tang J, Gawinecka J, Boesch L, Fraser WD, von Eckardstein A, Nowak A
                \nImpact of a single oral dose of 100,000 IU vitamin D3 on vitamin D metabolite profiles in healthy adults with vitamin D insufficiency
                \nClin Chem Lab Med. 2017 Mar 22 [Epub ahead of print]<\/li>\n
              21. Saleh L, Tang J, Gawinecka J, Boesch L, Fraser WD, von Eckardstein A, Nowak A
                \nImpact of a single oral dose of 100,000 IU vitamin D3 on vitamin D metabolite profiles in healthy adults with vitamin D insufficiency
                \nClin Chem Lab Med. 2017 Mar 22 [Epub ahead of print]<\/li>\n
              22. Nowak A, Mechtler TP, Kasper DC, Desnick RJ
                \nCorrelation of Lyso-Gb3 levels in Dried Blood Spots and Sera from patients with Classic and Later-Onset Fabry Disease
                \nMol Genet Metab. 2017 Aug;121(4):320-324<\/li>\n
              23. Nowak A, Franzen DP, Haile SR, Mottet D, Bonani M, Kohler M, Krayenbuehl PA, Barbey F
                \nLong-term follow-up of pulmonary function in Fabry disease: a multi-center observational study
                \nPLoS One. 2017 Jul 25;12(7):e0180437<\/li>\n
              24. Lenders M, Oder D, Nowak A, Canaan-K\u00fchl S, Arash-Kaps L, Drechsler C, Schmitz B, Nordbeck P, Hennermann JB, Kampmann C, Reuter S, Brand SM, Wanner C, Brand E.
                \nImpact of immunosuppressive therapy on therapy-neutralizing antibodies in transplanted patients with Fabry disease.
                \nJ Intern Med. 2017 Sep;282(3):241-253<\/li>\n
              25. Siegenthaler M, U. Huynh-Do U, Krayenbuehl P, Pollock E, Widmer U, Debaix H, Olinger E, Frank M, Namdar M, Ruschitzka F, Nowak A
                \nImpact of Cardio-Renal Syndrome on adverse outcomes in patients with Fabry disease in a long-term follow-up
                \nInternational Journal of Cardiology, in press<\/li>\n
              26. Annema W, Nowak A, von Eckardstein A, Saleh L
                \nEvaluation of the new restandardized Abbott Architect 25-OH Vitamin D assay in vitamin D-insufficient and vitamin D-supplemented individuals
                \nJ Clin Lab Anal. 2017 Sep 19 doi: 10.1002\/jcla.22328. [Epub ahead of print]<\/li>\n
              27. Nowak A, Mechtler TP, Hornemann T, Gawinecka J, Theswet E, Hilz MJ, Kasper DC
                \nGenotype, phenotype and disease severity reflected by serum LysoGb3 levels in patients with Fabry disease
                \nMol Genet Metab. 2017 Jul 5. pii: S1096-7192(17)30328-1 in press<\/li>\n<\/ol>\n

                REVIEW ARTICLES<\/h4>\n
                  \n
                1. G\u00f6ksu Y, Hofbauer G, Serra AL, Nowak A
                  \nMaligne Hauterkrankungen bei organtransplantierten Patienten
                  \nPraxis (Bern 1994). 2012;18;101(2):75-83<\/li>\n
                2. Mayer F, Hofbauer G, Nowak A
                  \nFr\u00fche kutane Karzinogenese bei organtransplantierten Patienten
                  \nPraxis (Bern 1994). 2012;31;101(22):1401-9<\/li>\n
                3. Nowak A, Krayenb\u00fchl P.-A
                  \nExtraskelettale Vitamin-D-Wirkungen
                  \nLeading Opinions 2013\/2; 8-12<\/li>\n
                4. Nowak A, L. Serra AL
                  \nAbkl\u00e4rung der Proteinurie
                  \nPraxis (Bern 1994). 2013 Jun 1;102(13):797-802<\/li>\n
                5. Hakman P, Vallelian F, Nowak A
                  \nRiesenzellarteriitis
                  \nPraxis (Bern 1994). 2013 Jun 5;102(12):703-8; quiz 709-10<\/li>\n
                6. M\u00fcggler A, Iseli SM, Meindl-Fridez C, Nowak A, Brunckhorst CB
                  \nAV-Knoten-Reentry-Tachykardie
                  \nPraxis (Bern 1994). 2013 Sept 1;102(19):1155-64<\/li>\n
                7. Nowak A, G\u00f6hner K, Cohen C
                  \nCaplan-Syndrom: eine untypische Differentialdiagnose des \u201epulmo-renalen\u201c Syndroms
                  \nPraxis (Bern 1994). 2014 Feb 26;103(5):279-84<\/li>\n
                8. Pollock E, Nowak A
                  \nThe cardio-renal problem
                  \nSwiss Med Wkly. 2014 Dec 4;144:w14051. doi: 10.4414\/smw.2014.14051<\/li>\n
                9. Steinack C, Gaspert A, Kovacs R, Nowak A
                  \nMorbus Fabry: Selten, aber nicht zu verpassen. CME
                  \nPraxis (Bern 1994). 2015 Jul;104(14):719-29<\/li>\n
                10. Rodieux F, Pfister M, van den Anker J, Rohrbach M, Schuknecht B, Gaspert A, Palla A, Nowak A
                  \nUnexplained peripheral neuropathic pain and\/or unexplained stroke in young patients – think about Fabry disease
                  \nSwiss Archives of Neurology, Psychiatry and Psychotherapy 2016 Apr;167(3)74-80<\/li>\n
                11. Schreiner F, Krayenb\u00fchl PA, Goede J, Nowak A
                  \nApproach to the Patient with Elevated Serum Ferritin
                  \nPraxis (Bern 1994). 2016 May 11;105(10):543-51<\/li>\n
                12. Nowak A
                  \nLinksherzhypertrophie \u2013 denken Sie an einen Morbus Fabry
                  \nCardiovascular Medicine. 2016;19(05)<\/li>\n
                13. Kr\u00fcger S, Nowak A, Lang K, M\u00fcller TC
                  \nCase report on General anesthesia and Fabry disease
                  \nA A Case Rep. 2017 May 15;8(10):247-249<\/li>\n
                14. Battegay E, Cheetham M, Holzer BM, Nowak A, Schmidt D, Rampini S
                  \nMultimorbidit\u00e4tsmanagement im Alltagsdilemma
                  \nDer Internist. 2017 DOI 10.1007\/s00108-017-0200-9<\/li>\n
                15. L\u00fcthi L, Andreas Kistler A, Nowak A
                  \nHyperkali\u00e4mie bei Patienten mit chronischer H\u00e4modialyse (exotische Ursache, lebensbedrohliche Folge)
                  \nPraxis (Bern 1994). 2017 Jun;106(12):679<\/li>\n
                16. Lecheler L, Richter M, Franzen DP, Rampini SK, Cheetham M, Jenewein J, Battegay E, Nowak A
                  \nThe frequent and underrecognized co-occurrence of Acute Exacerbated Chronic Obstructive Pulmonary Disease and Depression warrants screening: a systematic review
                  \nEur Respir Rev. 2017 Jun 14;26(144)<\/li>\n<\/ol>\n

                  BUECHER<\/h4>\n
                    \n
                  1. Frederique Barbey, Albina Nowak
                    \nDie Fabry Krankheit erkl\u00e4ren. Von \u00c4rzten f\u00fcr Kinder Verpasst! Medikidz 14 Basil Street, London 2017.<\/li>\n<\/ol>\n
                    \n
                    <\/div>\n
                    <\/div>\n
                    <\/div>\n<\/div>\n

                    [\/vc_column_text] <\/div>\n<\/div><\/div>[\/vc_column][\/vc_row][vc_row css_animation=\u00a0\u00bb\u00a0\u00bb row_type=\u00a0\u00bbrow\u00a0\u00bb use_row_as_full_screen_section=\u00a0\u00bbno\u00a0\u00bb type=\u00a0\u00bbfull_width\u00a0\u00bb angled_section=\u00a0\u00bbno\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb background_image_as_pattern=\u00a0\u00bbwithout_pattern\u00a0\u00bb][vc_column][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb][\/vc_column][\/vc_row][vc_row css_animation=\u00a0\u00bb\u00a0\u00bb row_type=\u00a0\u00bbrow\u00a0\u00bb use_row_as_full_screen_section=\u00a0\u00bbno\u00a0\u00bb type=\u00a0\u00bbfull_width\u00a0\u00bb angled_section=\u00a0\u00bbno\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb background_image_as_pattern=\u00a0\u00bbwithout_pattern\u00a0\u00bb][vc_column][vc_widget_sidebar sidebar_id=\u00a0\u00bbsidebar\u00a0\u00bb][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

                    [vc_row css_animation=\u00a0\u00bb\u00a0\u00bb row_type=\u00a0\u00bbrow\u00a0\u00bb use_row_as_full_screen_section=\u00a0\u00bbno\u00a0\u00bb type=\u00a0\u00bbfull_width\u00a0\u00bb angled_section=\u00a0\u00bbno\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb background_image_as_pattern=\u00a0\u00bbwithout_pattern\u00a0\u00bb][vc_column][vc_column_text] Expert Fabry en Suisse du Nord [\/vc_column_text][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb][\/vc_column][\/vc_row][vc_row css_animation=\u00a0\u00bb\u00a0\u00bb row_type=\u00a0\u00bbrow\u00a0\u00bb use_row_as_full_screen_section=\u00a0\u00bbno\u00a0\u00bb type=\u00a0\u00bbfull_width\u00a0\u00bb angled_section=\u00a0\u00bbno\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb background_image_as_pattern=\u00a0\u00bbwithout_pattern\u00a0\u00bb][vc_column width=\u00a0\u00bb1\/6″][vc_column_text][\/vc_column_text][\/vc_column][vc_column width=\u00a0\u00bb5\/6″][vc_column_text] PD Dr. med. Albina Nowak-Wilhelm Ober\u00e4rztin Klinik f\u00fcr Endokrinologie, Diabetologie und Klinische Ern\u00e4hrung Universit\u00e4tsspital Z\u00fcrich R\u00e4mistrasse 100 8091 Z\u00fcrich Tel.:…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-16285","page","type-page","status-publish","hentry"],"yoast_head":"\nSuisse du Nord - SFFD<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sffd.ch\/fr\/expert-fabry-suisse-du-nord\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Suisse du Nord - SFFD\" \/>\n<meta property=\"og:description\" content=\"[vc_row css_animation=\u00a0\u00bb\u00a0\u00bb row_type=\u00a0\u00bbrow\u00a0\u00bb use_row_as_full_screen_section=\u00a0\u00bbno\u00a0\u00bb type=\u00a0\u00bbfull_width\u00a0\u00bb angled_section=\u00a0\u00bbno\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb background_image_as_pattern=\u00a0\u00bbwithout_pattern\u00a0\u00bb][vc_column][vc_column_text] Expert Fabry en Suisse du Nord [\/vc_column_text][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb][\/vc_column][\/vc_row][vc_row css_animation=\u00a0\u00bb\u00a0\u00bb row_type=\u00a0\u00bbrow\u00a0\u00bb use_row_as_full_screen_section=\u00a0\u00bbno\u00a0\u00bb type=\u00a0\u00bbfull_width\u00a0\u00bb angled_section=\u00a0\u00bbno\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb background_image_as_pattern=\u00a0\u00bbwithout_pattern\u00a0\u00bb][vc_column width=\u00a0\u00bb1\/6″][vc_column_text][\/vc_column_text][\/vc_column][vc_column width=\u00a0\u00bb5\/6″][vc_column_text] PD Dr. med. Albina Nowak-Wilhelm Ober\u00e4rztin Klinik f\u00fcr Endokrinologie, Diabetologie und Klinische Ern\u00e4hrung Universit\u00e4tsspital Z\u00fcrich R\u00e4mistrasse 100 8091 Z\u00fcrich Tel.:...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sffd.ch\/fr\/expert-fabry-suisse-du-nord\/\" \/>\n<meta property=\"og:site_name\" content=\"SFFD\" \/>\n<meta property=\"article:modified_time\" content=\"2019-11-18T21:30:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sffd.ch\/wp-content\/uploads\/2017\/12\/albina_nowak.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"12 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/sffd.ch\\\/fr\\\/expert-fabry-suisse-du-nord\\\/\",\"url\":\"https:\\\/\\\/sffd.ch\\\/fr\\\/expert-fabry-suisse-du-nord\\\/\",\"name\":\"Suisse du Nord - SFFD\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/sffd.ch\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/sffd.ch\\\/fr\\\/expert-fabry-suisse-du-nord\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/sffd.ch\\\/fr\\\/expert-fabry-suisse-du-nord\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sffd.ch\\\/wp-content\\\/uploads\\\/2017\\\/12\\\/albina_nowak.jpg\",\"datePublished\":\"2017-12-13T19:20:23+00:00\",\"dateModified\":\"2019-11-18T21:30:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/sffd.ch\\\/fr\\\/expert-fabry-suisse-du-nord\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/sffd.ch\\\/fr\\\/expert-fabry-suisse-du-nord\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/sffd.ch\\\/fr\\\/expert-fabry-suisse-du-nord\\\/#primaryimage\",\"url\":\"https:\\\/\\\/sffd.ch\\\/wp-content\\\/uploads\\\/2017\\\/12\\\/albina_nowak.jpg\",\"contentUrl\":\"https:\\\/\\\/sffd.ch\\\/wp-content\\\/uploads\\\/2017\\\/12\\\/albina_nowak.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/sffd.ch\\\/fr\\\/expert-fabry-suisse-du-nord\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/sffd.ch\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Suisse du Nord\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/sffd.ch\\\/#website\",\"url\":\"https:\\\/\\\/sffd.ch\\\/\",\"name\":\"SFFD\",\"description\":\"Swiss Foundation of Fabry Disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/sffd.ch\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Suisse du Nord - SFFD","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sffd.ch\/fr\/expert-fabry-suisse-du-nord\/","og_locale":"fr_FR","og_type":"article","og_title":"Suisse du Nord - SFFD","og_description":"[vc_row css_animation=\u00a0\u00bb\u00a0\u00bb row_type=\u00a0\u00bbrow\u00a0\u00bb use_row_as_full_screen_section=\u00a0\u00bbno\u00a0\u00bb type=\u00a0\u00bbfull_width\u00a0\u00bb angled_section=\u00a0\u00bbno\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb background_image_as_pattern=\u00a0\u00bbwithout_pattern\u00a0\u00bb][vc_column][vc_column_text] Expert Fabry en Suisse du Nord [\/vc_column_text][vc_separator type=\u00a0\u00bbtransparent\u00a0\u00bb][\/vc_column][\/vc_row][vc_row css_animation=\u00a0\u00bb\u00a0\u00bb row_type=\u00a0\u00bbrow\u00a0\u00bb use_row_as_full_screen_section=\u00a0\u00bbno\u00a0\u00bb type=\u00a0\u00bbfull_width\u00a0\u00bb angled_section=\u00a0\u00bbno\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb background_image_as_pattern=\u00a0\u00bbwithout_pattern\u00a0\u00bb][vc_column width=\u00a0\u00bb1\/6″][vc_column_text][\/vc_column_text][\/vc_column][vc_column width=\u00a0\u00bb5\/6″][vc_column_text] PD Dr. med. Albina Nowak-Wilhelm Ober\u00e4rztin Klinik f\u00fcr Endokrinologie, Diabetologie und Klinische Ern\u00e4hrung Universit\u00e4tsspital Z\u00fcrich R\u00e4mistrasse 100 8091 Z\u00fcrich Tel.:...","og_url":"https:\/\/sffd.ch\/fr\/expert-fabry-suisse-du-nord\/","og_site_name":"SFFD","article_modified_time":"2019-11-18T21:30:35+00:00","og_image":[{"url":"https:\/\/sffd.ch\/wp-content\/uploads\/2017\/12\/albina_nowak.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/sffd.ch\/fr\/expert-fabry-suisse-du-nord\/","url":"https:\/\/sffd.ch\/fr\/expert-fabry-suisse-du-nord\/","name":"Suisse du Nord - SFFD","isPartOf":{"@id":"https:\/\/sffd.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sffd.ch\/fr\/expert-fabry-suisse-du-nord\/#primaryimage"},"image":{"@id":"https:\/\/sffd.ch\/fr\/expert-fabry-suisse-du-nord\/#primaryimage"},"thumbnailUrl":"https:\/\/sffd.ch\/wp-content\/uploads\/2017\/12\/albina_nowak.jpg","datePublished":"2017-12-13T19:20:23+00:00","dateModified":"2019-11-18T21:30:35+00:00","breadcrumb":{"@id":"https:\/\/sffd.ch\/fr\/expert-fabry-suisse-du-nord\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sffd.ch\/fr\/expert-fabry-suisse-du-nord\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/sffd.ch\/fr\/expert-fabry-suisse-du-nord\/#primaryimage","url":"https:\/\/sffd.ch\/wp-content\/uploads\/2017\/12\/albina_nowak.jpg","contentUrl":"https:\/\/sffd.ch\/wp-content\/uploads\/2017\/12\/albina_nowak.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/sffd.ch\/fr\/expert-fabry-suisse-du-nord\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/sffd.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"Suisse du Nord"}]},{"@type":"WebSite","@id":"https:\/\/sffd.ch\/#website","url":"https:\/\/sffd.ch\/","name":"SFFD","description":"Swiss Foundation of Fabry Disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sffd.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/sffd.ch\/fr\/wp-json\/wp\/v2\/pages\/16285","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sffd.ch\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sffd.ch\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sffd.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/sffd.ch\/fr\/wp-json\/wp\/v2\/comments?post=16285"}],"version-history":[{"count":20,"href":"https:\/\/sffd.ch\/fr\/wp-json\/wp\/v2\/pages\/16285\/revisions"}],"predecessor-version":[{"id":16833,"href":"https:\/\/sffd.ch\/fr\/wp-json\/wp\/v2\/pages\/16285\/revisions\/16833"}],"wp:attachment":[{"href":"https:\/\/sffd.ch\/fr\/wp-json\/wp\/v2\/media?parent=16285"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}